Publications by authors named "Merce Amat"

Claim this Profile
A
A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial.
Oscar Buisan, Pol Servian, Sonia Pedreño-Lopez, Joan Pagès, Victor Urrea, Mercè Amat

Eur Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RUTI Vaccination Enhances Inhibition of Mycobacterial Growth and Induces a Shift of Monocyte Phenotype in Mice.
Satria A Prabowo, Hannah Painter, Andrea Zelmer, Steven G Smith, Karin Seifert, Merce Amat

Front Immunol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS).
Marzio Pennisi, Giulia Russo, Giuseppe Sgroi, Angela Bonaccorso, Giuseppe Alessandro Parasiliti Palumbo, Merce Amat

BMC Bioinformatics· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection.
Andre S Nell, Eva D'lom, Patrick Bouic, Montserrat Sabaté, Ramon Bosser, Mercè Amat

PLoS One· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racemic and chiral sulfoxides as potential prodrugs of 4-pyrone COX-2 inhibitors.
Francisco Caturla, Mercè Amat, Raquel F Reinoso, Elena Calaf, Graham Warrellow

Bioorg Med Chem Lett· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racemic and chiral sulfoxides as potential prodrugs of the COX-2 inhibitors Vioxx and Arcoxia.
Francisco Caturla, Mercè Amat, Raquel F Reinoso, Mónica Córdoba, Graham Warrellow

Bioorg Med Chem Lett· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of 2-phenylpyran-4-ones: a new class of orally active cyclooxygenase-2 inhibitors.
Francisco Caturla, Juan-Miguel Jiménez, Núria Godessart, Mercè Amat, Alvaro Cárdenas

J Med Chem· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amide derivatives of [5-chloro-6-(2-chloro/fluorobenzoyl)-2-benzoxazolinone-3-yl]acetic acids as potential analgesic and anti-inflammatory compounds.
Erden Banoglu, Berna Okçelik, Esra Kupeli, Serdar Unlü, Erdem Yeşilada, Mercé Amat

Arch Pharm (Weinheim)· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis